A nurse is caring for a client following an amniocentesis.
The nurse should observe the client for which of the following complications?

Choice A rationale

A pounding headache, visual changes, and epigastric pain in a patient with pregnancy-induced hypertension (PIH), now known as gestational hypertension or preeclampsia, are serious signs indicating worsening disease severity. These symptoms suggest central nervous system irritability (headache, visual changes) and potential liver involvement or severe preeclampsia (epigastric pain), increasing the risk of eclampsia, which is characterized by seizures.

Choice B rationale

Magnesium sulfate is a medication commonly used to prevent seizures in patients with severe preeclampsia. While it can cause side effects such as flushing, warmth, and muscle weakness, it does not typically cause a pounding headache, visual changes, or epigastric pain. These symptoms are indicative of the underlying disease process, not the medication.

Choice C rationale

While hospitalization can induce anxiety in some patients, the specific combination of a pounding headache, visual changes, and epigastric pain in the context of pregnancy-induced hypertension strongly suggests a physiological basis related to the worsening of the hypertensive disorder, rather than solely psychological distress.

Choice D rationale

While epigastric pain can be associated with gastrointestinal issues, in a patient with pregnancy-induced hypertension experiencing a pounding headache and visual changes concurrently, it is more likely related to hepatic involvement or severe preeclampsia. A focused assessment of the gastrointestinal system alone would not adequately address the potential severity of the situation.

The nurse should monitor the client’s temperature due to the risk of chorioamnionitis.

Rationale for correct answers

Temperature monitoring is crucial for detecting chorioamnionitis, an infection of the amniotic sac, which is a major risk following preterm premature rupture of membranes (PPROM). PPROM increases susceptibility to ascending bacterial infection, leading to inflammation. Fever (>38°C or 100.4°F) is a primary diagnostic criterion.

Chorioamnionitis presents with maternal fever, fetal tachycardia (>160/min), uterine tenderness, and foul-smelling amniotic fluid. The client's normal temperature now (36.7°C) requires ongoing monitoring, as infection could develop rapidly.

Rationale for incorrect Response 1 options

• Magnesium levels: Magnesium sulfate is used for seizure prophylaxis in eclampsia or for neuroprotection in preterm labor. This client has no signs of either condition.
• Fundal height: Measurement assesses fetal growth and amniotic fluid levels; it is not a direct indicator of infection risk.
• Clotting factors: No evidence of coagulopathy or bleeding abnormalities; coagulation profile is normal.

Rationale for incorrect Response 2 options

• Concealed hemorrhage: No signs of placental abruption (painful bleeding, rigid abdomen). Normal hemoglobin (12.0 g/dL) supports this.
• Seizures: No hypertensive crisis or neurological symptoms suggestive of eclampsia.
• Disseminated intravascular coagulation (DIC): No abnormal coagulation markers or evidence of excessive bleeding.

Take-home points

• PPROM increases the risk of chorioamnionitis, a serious intrauterine infection. • Fever monitoring is essential, as maternal fever is an early indicator of infection. • Antibiotics are given prophylactically to reduce chorioamnionitis risk in PPROM. • Differentiation from placental abruption, eclampsia, and DIC is based on clinical and laboratory findings.